NCT06526819View on ClinicalTrials.gov

SMP-3124LP in Adults With Advanced Solid Tumors

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

May 31, 2029

Conditions
Solid Tumor
Interventions
DRUG

SMP3124LP

Liposomal encapsulation formulation of SMP-3124

Trial Locations (6)

37203

RECRUITING

SCRI Oncology Partners, Nashville

37232

RECRUITING

Vanderbilt-Ingram Cancer Center, Nashville

43210

RECRUITING

Ohio State University, Columbus

77030

RECRUITING

MD Anderson Cancer Center, Houston

80218

RECRUITING

Sarah Cannon Research Institute at HealthOne, Denver

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa-shi

All Listed Sponsors
lead

Sumitomo Pharma America, Inc.

INDUSTRY